UBS AG reiterated their neutral rating on shares of Cardinal Health, Inc. (NYSE:CAH) in a research report report published on Thursday. They currently have a $76.00 price objective on the stock, down from their previous price objective of $79.00.
CAH has been the topic of a number of other reports. Credit Suisse Group reaffirmed an outperform rating and set a $87.00 price target (up from $81.00) on shares of Cardinal Health in a research report on Thursday, July 13th. William Blair lowered shares of Cardinal Health from an outperform rating to a market perform rating in a research report on Wednesday, April 19th. Barclays PLC reaffirmed an overweight rating and set a $82.00 price target (down from $88.00) on shares of Cardinal Health in a research report on Saturday, April 22nd. BidaskClub lowered shares of Cardinal Health from a buy rating to a hold rating in a research report on Monday, July 24th. Finally, Jefferies Group LLC assumed coverage on shares of Cardinal Health in a research report on Wednesday, May 17th. They set a hold rating and a $77.00 price target on the stock. Two analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have issued a buy rating to the stock. The stock has an average rating of Hold and an average target price of $81.07.
Cardinal Health (CAH) traded down 0.32% during mid-day trading on Thursday, reaching $69.14. 2,406,963 shares of the company were exchanged. Cardinal Health has a 12-month low of $62.70 and a 12-month high of $84.90. The company’s 50 day moving average price is $77.38 and its 200-day moving average price is $77.27. The stock has a market capitalization of $21.85 billion, a price-to-earnings ratio of 17.16 and a beta of 0.80.
Cardinal Health (NYSE:CAH) last posted its earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.07. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The company had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. During the same quarter last year, the company posted $1.14 EPS. Cardinal Health’s quarterly revenue was up 5.0% compared to the same quarter last year. On average, equities research analysts forecast that Cardinal Health will post $5.07 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This article was first published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://stocknewstimes.com/2017/08/05/cardinal-health-inc-cah-receives-neutral-rating-from-ubs-ag.html.
In other Cardinal Health news, CEO of Cardinal Health’s pharmaceutical segment Jon L. Giacomin sold 23,270 shares of the firm’s stock in a transaction dated Friday, May 12th. The shares were sold at an average price of $72.87, for a total value of $1,695,684.90. Following the transaction, the insider now directly owns 55,440 shares of the company’s stock, valued at approximately $4,039,912.80. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.94% of the stock is owned by company insiders.
Several large investors have recently made changes to their positions in CAH. Advisory Services Network LLC bought a new stake in shares of Cardinal Health during the first quarter valued at about $120,000. JFS Wealth Advisors LLC raised its stake in shares of Cardinal Health by 14.3% in the second quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock valued at $152,000 after buying an additional 244 shares during the period. Quadrant Capital Group LLC raised its stake in shares of Cardinal Health by 6.3% in the first quarter. Quadrant Capital Group LLC now owns 1,972 shares of the company’s stock valued at $156,000 after buying an additional 116 shares during the period. Dupont Capital Management Corp bought a new stake in shares of Cardinal Health during the second quarter valued at about $164,000. Finally, First Personal Financial Services raised its stake in shares of Cardinal Health by 127.5% in the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock valued at $172,000 after buying an additional 1,238 shares during the period. 87.31% of the stock is currently owned by institutional investors.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
